Covid: Lateral flow tests more accurate than first thought, study finds

Lateral flow tests (LFTs) are very good at detecting people most likely to spread Covid-19 and positive results should be trusted, say University College London researchers. When LFTs were introduced, they were criticised for being less accurate than PCR tests, which are analysed in a lab. But the study found rapid tests were “a very useful public health tool” for stopping the spread of the virus.

One third of people with Covid can spread it while showing no symptoms. Based on the UCL research, Prof Irene Petersen, lead study author, said people who get a positive LFT result “should trust them and stay at home”. But government guidance says people must get a follow-up PCR test after a positive LFT to confirm they have Covid – and they can end their self-isolation when they get a negative result in a PCR test.

There have been recent reports of this happening in south-west England, leaving people unsure whether to isolate or not. The UK’s Health Security Agency said it was looking into the cause, but there was no evidence of any technical issues with test kits. Prof Petersen said: “When [Covid is] more common, there is no need to confirm it with a PCR – it’s more likely it is a positive,” she said.

When the researchers used a new formula for calculating the rapid test’s accuracy, they found LFTs were more than 80% effective at detecting any level of Covid-19 infection and likely to be more than 90% effective at detecting who is most infectious when they use the test. This is much higher than previously thought, they say. Prof Michael Mina, from Harvard School of Public Health, also part of the research team, said the LFTs could “catch nearly everyone who is currently a serious risk to public health” when viral loads are at their peak.

“It is most likely that if someone’s LFT is negative but their PCR is positive, then this is because they are not at peak transmissible stage,” he said. The rapid tests are widely used in schools, workplaces and for allowing entry to large events to test those with no symptoms.

Since they were introduced in secondary schools in England in March, NHS Test and Trace figures show 103,409 LFT tests have come back positive, 79,000 were matched with a confirmatory PCR and 69,500 of those were confirmed positive (and 7,647 came back negative). There was much criticism of the rapid tests when they were first trialled in Liverpool last year because they were directly compared to PCR tests, which were often described as the gold standard. “This is like comparing apples and oranges,” Prof Petersen said.

Lateral flow tests and PCR (polymerase chain reaction) tests do different things:

  • LFTs pick up the most infectious people by detecting material from the surface proteins of the virus
  • PCRs detect genetic material of the virus which can be present in the body for several weeks after somebody is actually capable of passing it on

The UCL peer-reviewed study concludes that criticism of LFTs for low sensitivity “have reached the wrong conclusions”, “confused policy-making” and “damaged public trust in LFTs”. Health professionals and the public should be aware of what the tests do, said the researchers, writing in Clinical Epidemiology. And they acknowledge that errors in the way people take the tests or in the way they are processed in the lab could affect results – and these factors were not taken into account in their study. The current government guidance says that if you receive a negative follow-up PCR test result, and this PCR test was taken within two days of the positive LFT, you will be told by NHS Test and Trace that you can stop self-isolating.

However, it states that you must continue to self-isolate if the PCR result is positive, you choose not to take a follow-up PCR or the test was taken more than two days after the positive LFT. Dr Sophia Makki, incident director for Covid-19 at the UK Health Security Agency, said: “Around one in three people who have Covid-19 never show any symptoms. “Using LFDs (lateral flow devices) help to find asymptomatic cases who have a high viral load and are most likely to pass on the virus to others.”


We first ordered products from Hygiene UK at the start of the pandemic as our usual suppliers could not supply, and had increased their prices drastically. We were offered competitively priced and good quality PPE at a time when not many suppliers could. You delivered timely deliveries to all of my locations, and your team are always friendly and helpful. I will continue to work with you when required.

We've used Hygiene UK many times and have nothing but good things to say. Great Prices, reliable & quick delivery. We use Hygiene UK to supply our blue-chip clients so confidence is a must! Thoroughly recommend!

A vast range of PPE products at competitive prices, but crucially the expertise behind the products and the quality of them is second to none.

A great company to deal with, extremely reliable with a good range of products. Excellent product knowledge, great communication & customer service, fair prices and fast delivery.

Hygiene UK is great business providing essential supplies to essential services.

Huge range of products at great prices. At a time of desperate need many were taking advantage of people, but not Hygiene UK. They have helped us and have been nothing but perfect. If you’re looking for masks, gloves, aprons, etc please give the team at Hygiene UK a call!

Pleasure to deal with, great communication and overall service levels. Highly recommended.

Get in touch

We would love to hear from you whether it be a business or product enquiry. Complete the form below and submit.


    Find what you might need in our FAQ's...

    An IVD Medical Device is defined in the IVDR as “any medical device which is a reagent, reagent product, calibrator, control material, kit, instrument, apparatus, piece of equipment, software or system, whether used alone or in combination, intended by the manufacturer to be used in vitro for the examination of specimens derived from the human body.

    In vitro diagnostics (IVDs) are tests that can detect disease, conditions and infections. In vitro simply means 'in glass', meaning these tests are typically conducted in test tubes, cassettes and similar equipment, as opposed to in vivo tests, which are conducted in the body itself.

    The IVDR is the new regulatory basis for placing on the market, making available and putting into service in vitro diagnostic medical devices on the European market. It will replace the EU’s current Directive on in vitro diagnostic medical devices (98/79/EC). As a European regulation, it will be effective in all EU member states and EFTA states immediately without need to be transferred into the law of respective states, however national laws may be adapted to back up some requirements in more detail.

    The IVDR came into force on 25 May 2017. Several implementing acts/guidance documents are being issued by the EU commission and are stipulated to complete some of the requirements to be met.

    All the usual methods of communication can be used, phone, email, and the contact form on the website. Whichever method suits your needs best, check out the website footer for our contact information. Additionally if you need a face to face meeting we are more than happy to come visit.

    Read more FAQs

    Copyright © 2020 Hygiene UK

    Registered in England & Wales. Company Number: 12595581. VAT Registration: 348 0375 93

    Website from Skratch